Nanobiotix (NBTX) Earnings Analysis

Nanobiotix (NBTX) next reports earnings on 2026-09-30, consensus EPS -0.31556 USD. Last quarter (2026-03-31) it missed with EPS -0.45809 USD vs 0.3039 USD est (-250.7%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -68.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NBTX next report earnings?

Next earnings date2026-09-30
Consensus EPS estimate-0.31556 USD
Revenue estimate0.02B

NBTX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-31-0.45809 USD0.3039 USD-250.7%Miss
2025-09-30-0.13367 USD-0.24704 USD+45.9%Beat
2025-04-02-1.01347 USD-0.62 USD-63.5%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

NBTX valuation and analyst view

Trailing P/E-68.55
Trailing EPS-0.50531 USD
Price / book-19.62
Dividend yield0.00%
Market cap2.01B
Analyst consensusBuy (3 buy / 1 hold / 0 sell)
Avg price target38 USD

Related research pages

Frequently asked questions

When is Nanobiotix (NBTX)'s next earnings date?

Nanobiotix is next scheduled to report on 2026-09-30, with a consensus EPS estimate of -0.31556 USD and revenue estimate of 0.02B.

Did NBTX beat earnings last quarter?

In its 2026-03-31 report, NBTX posted EPS of -0.45809 USD versus a 0.3039 USD estimate — a miss of 250.7%.

What is NBTX's earnings track record?

Over the last 3 reported quarters with consensus data, NBTX beat estimates 1 times (33%).

What is NBTX's current P/E ratio and EPS?

NBTX trades at a trailing P/E of -68.55 on trailing EPS of -0.5053086937157638 USD.

What do analysts rate NBTX?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 38 USD.